XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
STATEMENTS OF CONSOLIDATED INCOME (LOSS) - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 3,024.0 $ 3,087.0 $ 3,427.9
Costs and expenses:      
Cost of products sold, excluding depreciation and amortization 2,691.1 2,754.9 3,180.2
Depreciation and amortization 116.4 108.6 106.9
Selling, general, administrative, research and development 120.8 122.7 110.9
Goodwill impairment 0.0 0.0 20.5
Restructuring costs 7.6 5.0 2.2
Other operating charges, net 0.4 0.0 3.2
Total costs and expenses 2,936.3 2,991.2 3,423.9
Operating income 87.7 95.8 4.0
Other (expense) income:      
Interest expense (43.7) (46.9) (48.3)
Other income, net - Note 13 19.5 7.4 6.4
Income (loss) before income taxes 63.5 56.3 (37.9)
Income tax (provision) benefit (16.7) (9.1) 8.3
Net income (loss) $ 46.8 $ 47.2 $ (29.6)
Net income (loss) per common share:      
Basic $ 2.91 $ 2.95 $ (1.86)
Diluted $ 2.87 $ 2.92 $ (1.86)
Weighted-average number of common shares outstanding (in thousands):      
Basic 16,069 15,991 15,906
Diluted 16,319 16,131 15,906